Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (3y) (2012 - 2018)
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (3y) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.17% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -43.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -66.89% |
| Dec 31, 2017 | -7.77% |
| Sep 30, 2017 | -4.55% |
| Jun 30, 2017 | 60.12% |
| Mar 31, 2017 | -141.73% |
| Dec 31, 2016 | -66.19% |
| Sep 30, 2016 | -39.24% |
| Jun 30, 2016 | -1.55% |
| Mar 31, 2016 | -8.73% |
| Dec 31, 2015 | 7.41% |
| Sep 30, 2015 | 1.58% |
| Jun 30, 2015 | -3.63% |
| Mar 31, 2015 | -11.75% |
| Dec 31, 2014 | 3.08% |
| Sep 30, 2014 | -37.43% |
| Jun 30, 2014 | 23.38% |
| Mar 31, 2014 | 12.36% |
| Dec 31, 2013 | 40.52% |
| Sep 30, 2013 | 95.38% |
| Jun 30, 2013 | 27.17% |